• No results found

syncytial virus (RSV)

Recombinant Vaccinia Virus Coexpressing the F Protein of Respiratory Syncytial Virus (RSV) and Interleukin-4 (IL-4) Does Not Inhibit the Development of RSV-Specific Memory Cytotoxic T Lymphocytes, whereas Priming Is Diminished in the Presence of High Leve

Recombinant Vaccinia Virus Coexpressing the F Protein of Respiratory Syncytial Virus (RSV) and Interleukin-4 (IL-4) Does Not Inhibit the Development of RSV-Specific Memory Cytotoxic T Lymphocytes, whereas Priming Is Diminished in the Presence of High Levels of IL-2 or Gamma Interferon

... respiratory syncytial virus (RSV) could be influenced by cytokines, recombinant vaccinia viruses (rVV) carrying both the F gene of RSV and the gene for murine interleukin-2 (IL-2), IL-4, or ...

8

Addition of a Missense Mutation Present in the L Gene of Respiratory Syncytial Virus (RSV) cpts530/1030 to RSV Vaccine Candidate  cpts248/404 Increases Its Attenuation and  Temperature Sensitivity

Addition of a Missense Mutation Present in the L Gene of Respiratory Syncytial Virus (RSV) cpts530/1030 to RSV Vaccine Candidate cpts248/404 Increases Its Attenuation and Temperature Sensitivity

... Respiratory syncytial virus (RSV) cpts530/1030 is an attenuated, temperature-sensitive subgroup A vaccine candidate derived previously from cold-passaged RSV (cpRSV) by two sequential rounds ...

7

Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection

Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection

... respiratory syncytial virus (RSV) is the principal viral cause of serious lower respiratory tract infection (LRTI) in infants and young children, immunocomprom- ised and cardiopulmonary diseased ...

10

Respiratory syncytial virus: current and emerging treatment options

Respiratory syncytial virus: current and emerging treatment options

... Respiratory syncytial virus (RSV) is an important respiratory pathogen in infants and children ...Although RSV typically causes mild upper respiratory infections, it frequently causes severe ...

9

Chimeric Bovine/Human Parainfluenza Virus Type 3 Expressing Respiratory Syncytial Virus (RSV) F Glycoprotein: Effect of Insert Position on Expression, Replication, Immunogenicity, Stability, and Protection against RSV Infection

Chimeric Bovine/Human Parainfluenza Virus Type 3 Expressing Respiratory Syncytial Virus (RSV) F Glycoprotein: Effect of Insert Position on Expression, Replication, Immunogenicity, Stability, and Protection against RSV Infection

... 3 virus (rB/HPIV3) vector expressing the respiratory syncytial virus (RSV) fusion F glycoprotein previously exhibited disappointing levels of RSV F immunogenicity and genetic stability ...

14

Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem

Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem

... Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infection (LRTI) annually affecting ⬎ 2 million children in the United States ⬍ 5 years ...old), RSV results in ⬃ ...

8

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease

... respiratory syncytial virus (RSV) experi- enced an enhanced form of RSV disease characterized by high fever, bronchopneumonia, and wheezing when they became in- fected with wild-type ...

7

Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus Infections

Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus Infections

... Respiratory Syncytial Virus Immune Globulin Intravenous (RSV-IGIV) are li- censed by the Food and Drug Administration for use in preventing severe respiratory syncytial virus ...

8

Respiratory Syncytial Virus (RSV) Infection in Preterm Infants and the Protective Effects of RSV Immune Globulin (RSVIG)

Respiratory Syncytial Virus (RSV) Infection in Preterm Infants and the Protective Effects of RSV Immune Globulin (RSVIG)

... To evaluate the safety and ef- ficacy of respiratory syncytial virus immune globulin (RSVIG) in the prevention of severe respiratory syncytial virus (RSV) lower respiratory tract infecti[r] ...

7

Respiratory Syncytial Virus PREVENT Study Questions

Respiratory Syncytial Virus PREVENT Study Questions

... respiratory syncytial virus (RSV)- associated hospital ...severe RSV disease who received monthly RSV-IGIV prophylaxis had a sig- nificant reduction in the incidence (41%) and total ...

5

A Novel Influenza Virus Hemagglutinin-Respiratory Syncytial Virus (RSV) Fusion Protein Subunit Vaccine against Influenza and RSV

A Novel Influenza Virus Hemagglutinin-Respiratory Syncytial Virus (RSV) Fusion Protein Subunit Vaccine against Influenza and RSV

... nfluenza virus and respiratory syncytial virus (RSV) may cause respiratory tract illness in individuals of all ages, but they have particular impact on the young and the elderly ...influenza ...

13

Respiratory syncytial virus hospitalization trends in infants with chronic lung disease of infancy, 1998–2008

Respiratory syncytial virus hospitalization trends in infants with chronic lung disease of infancy, 1998–2008

... respiratory syncytial virus (RSV) illness requiring ...of RSV disease in high-risk infants, including those with ...to RSV (RSVH) since the launch of ...

6

Parainfluenza Virus 5 Expressing Wild-Type or Prefusion Respiratory Syncytial Virus (RSV) Fusion Protein Protects Mice and Cotton Rats from RSV Challenge

Parainfluenza Virus 5 Expressing Wild-Type or Prefusion Respiratory Syncytial Virus (RSV) Fusion Protein Protects Mice and Cotton Rats from RSV Challenge

... respiratory syncytial virus (RSV) is the leading cause of pediatric bronchiolitis and ...hospitalizations. RSV can also cause severe complications in elderly and immunocompromised ...

17

Evaluation of five methods for respiratory syncytial virus detection

Evaluation of five methods for respiratory syncytial virus detection

... A total of 117 nasal aspirates were cultured for respiratory syncytial virus RSV and tested for RSV antigen by a direct fluorescent-antibody DFA test Bartels Immunodiagnostic Supplies, I[r] ...

5

Agreement between ELISA and plaque reduction neutralisation assay in detection of respiratory syncytial virus specific antibodies in a birth Cohort from Kilifi, coastal Kenya

Agreement between ELISA and plaque reduction neutralisation assay in detection of respiratory syncytial virus specific antibodies in a birth Cohort from Kilifi, coastal Kenya

... of RSV lysate (antigen), while the other half (column 7-12) was coated with 50µl/well of mock lysate ...without RSV virus prepared using same procedure as that of the RSV ...

17

Respiratory Syncytial Virus Immune Globulin Treatment of RSV Lower Respiratory Tract Infection in Previously Healthy Children

Respiratory Syncytial Virus Immune Globulin Treatment of RSV Lower Respiratory Tract Infection in Previously Healthy Children

... The study population was composed of previously healthy infants and young children who were enrolled at Children’s Na- tional Medical Center in Washington, DC; The Children’s Hospital in Denver, Colorado; Vanderbilt ...

8

Replication-Competent or Attenuated, Nonpropagating Vesicular Stomatitis Viruses Expressing Respiratory Syncytial Virus (RSV) Antigens Protect Mice against RSV Challenge

Replication-Competent or Attenuated, Nonpropagating Vesicular Stomatitis Viruses Expressing Respiratory Syncytial Virus (RSV) Antigens Protect Mice against RSV Challenge

... The RSV virion envelope contains three viral encoded gly- coproteins (8). RSV G (attachment) and F (fusion), the major antigenic glycoproteins, are responsible for viral attachment and ...unknown. ...

9

Mathematical models for respiratory syncytial virus (RSV) transmission

Mathematical models for respiratory syncytial virus (RSV) transmission

... modelling multiple strains and interaction with other respiratory viruses; and further in- vestigation of vaccine programs as vaccine candidates progress through clinical trials. Although I identified that the birth rate ...

188

Cost-effectiveness of Respiratory Syncytial Virus Prophylaxis Among Preterm Infants

Cost-effectiveness of Respiratory Syncytial Virus Prophylaxis Among Preterm Infants

... for RSV ($5000 – $25 000). We also varied the probabilities of RSV hospitalization from half to double those assumed in the base ...of RSV because of bias in the reference ...

11

Reducing the Morbidity of Lower Respiratory Tract Infections Caused by Respiratory Syncytial Virus: Still No Answer

Reducing the Morbidity of Lower Respiratory Tract Infections Caused by Respiratory Syncytial Virus: Still No Answer

... this month’s Pediatrics electronic pages evaluates the role of ribavirin in the hospital course of 750 high- risk Canadian infants and children with lower respi- ratory tract infection caused by RSV. Ribavirin use ...

6

Show all 10000 documents...

Related subjects